We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+5.89%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$53.6B
AUM Growth
+$2.66B
(+5.2%)
Cap. Flow
+$86.8M
Cap. Flow
% of AUM
0.16%
Top 10 Holdings %
Top 10 Hldgs %
37.17%
Holding
821
New
56
Increased
227
Reduced
258
Closed
253
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$86.2M |
| 2 |
Alcon
ALC
|
+$81.8M |
| 3 |
NVIDIA
NVDA
|
+$76M |
| 4 |
Corning
GLW
|
+$50.4M |
| 5 |
UnitedHealth
UNH
|
+$42.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$67.4M |
| 2 |
Factset
FDS
|
+$62M |
| 3 |
Euronet Worldwide
EEFT
|
+$42.3M |
| 4 |
Bank of America Series L
BAC.PRL
|
+$39.5M |
| 5 |
OPLN
Openlane
OPLN
|
+$31.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.75% |
| 2 | Consumer Discretionary | 17.74% |
| 3 | Financials | 11.65% |
| 4 | Healthcare | 11.2% |
| 5 | Communication Services | 10.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Carter's
CRI
$1.47B
| $9.65M | 0.02% |
98,933
-5,940
| -6% | -$578K |
|
327
Darling Ingredients
DAR
$9.44B
| $9.62M | 0.02% |
483,529
-8,225
| -2% | -$169K |
|
328
QuidelOrtho
QDEL
$838M
| $9.6M | 0.02% |
161,873
-2,751
| -2% | -$165K |
|
329
Jazz Pharmaceuticals
JAZZ
$16.7B
| $9.54M | 0.02% |
66,892
+6,643
| +11% | +$893K |
|
330
Sprouts Farmers Market
SFM
$8.01B
| $9.43M | 0.02% |
499,373
-30,016
| -6% | -$625K |
|
331
Pathward Financial
CASH
$1.8B
| $9.41M | 0.02% |
335,623
-30,197
| -8% | -$768K |
|
332
Donnelley Financial Solutions
DFIN
$1.16B
| $9.33M | 0.02% |
699,388
-68,542
| -9% | -$967K |
|
333
Urban Outfitters
URBN
$6.59B
| $9.3M | 0.02% |
409,004
+27,688
| +7% | +$750K |
|
334
SouthState Bank Corp
SSB
$10.5B
| $9.29M | 0.02% |
126,141
-6,253
| -5% | -$449K |
|
335
Ares Capital
ARCC
$14.4B
| $9.28M | 0.02% |
517,535
-29,231
| -5% | -$517K |
|
336
Packaging Corp of America
PKG
$22.8B
| $8.85M | 0.02% |
92,859
-4,678
| -5% | -$451K |
|
337
TTM Technologies
TTMI
$14.5B
| $8.85M | 0.02% |
867,574
+113,636
| +15% | +$1.26M |
|
|
CORE
338
DELISTED
Core Mark Holding Co., Inc.
CORE
| $8.55M | 0.02% |
215,189
+109,139
| +103% | +$4.1M |
|
339
Dolby
DLB
$5.79B
| $8.48M | 0.02% |
131,303
-7,030
| -5% | -$448K |
|
340
Federal Agricultural Mortgage
AGM
$2.56B
| $8.46M | 0.02% |
116,424
-13,780
| -11% | -$1.01M |
|
|
CRAY
341
DELISTED
Cray, Inc.
CRAY
| $8.43M | 0.02% |
242,228
-36,422
| -13% | -$1.13M |
|
342
BWX Technologies
BWXT
$15.6B
| $8.41M | 0.02% |
161,349
-2,657
| -2% | -$133K |
|
343
JB Hunt Transport Services
JBHT
$25.2B
| $8.38M | 0.02% |
91,647
-4,653
| -5% | -$439K |
|
344
Globus Medical
GMED
$11.2B
| $8.34M | 0.02% |
197,097
-11,859
| -6% | -$515K |
|
345
Ares Management
ARES
$30.9B
| $8.32M | 0.02% |
+317,920
| New | +$8.07M |
|
346
nVent Electric
NVT
$26.7B
| $8.25M | 0.02% |
332,739
-32,641
| -9% | -$841K |
|
347
Clarivate
CLVT
$1.16B
| $8.25M | 0.02% |
+536,185
| New | +$7.48M |
|
|
BIG
348
DELISTED
Big Lots, Inc.
BIG
| $8.24M | 0.02% |
288,128
-27,071
| -9% | -$904K |
|
|
AMWD
349
DELISTED
American Woodmark
AMWD
| $8.16M | 0.02% |
96,390
-1,606
| -2% | -$135K |
|
350
ATI
ATI
$31B
| $8.12M | 0.02% |
+322,244
| New | +$7.85M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2019 Portfolio in Review
As of Q2 2019, Loomis, Sayles & Company held 821 positions worth $53.6B, up 5.2% from $50.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Loomis, Sayles & Company's Q2 2019 filing shows 56 new, 227 increased, 258 reduced and 253 closed positions. Its largest new stake was Alcon: 1,393,674 shares worth $86.5M. The largest sale was Novartis, an estimated $67.4M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- Loomis, Sayles & Company's largest Q2 2019 buy was Alcon: 1,393,674 shares worth $86.5M.
- Loomis, Sayles & Company added most to Bristol-Myers Squibb in Q2 2019, an estimated $86.2M increase.
- Loomis, Sayles & Company's biggest Q2 2019 reduction was Novartis, cutting an estimated $67.4M.
- Loomis, Sayles & Company fully exited RingCentral in Q2 2019, selling an estimated $30.4M.
- Loomis, Sayles & Company's ten largest holdings make up 37% of its $53.6B portfolio in Q2 2019.
- Loomis, Sayles & Company opened 56 new positions and closed 253 in Q2 2019.
- Loomis, Sayles & Company's portfolio value rose 5.2% quarter-over-quarter to $53.6B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2019, filed 14 Aug 2019.